Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) for metastatic NSCLC: Tissue TMB (tTMB) and outcomes in KEYNOTE-021, 189, and 407
Year: 2019
Type: article
Source: Annals of Oncology
Institutions: Universidad Complutense de Madrid, Hospital Universitario 12 De Octubre, Abramson Cancer Center, University of Pennsylvania, University of Turin, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Jilin Province Tumor Hospital, University of Michigan, The Barbara Ann Karmanos Cancer Institute, The University of Sydney, Westmead Hospital, Sendai Kousei Hospital, Fox Chase Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Fondazione IRCCS Istituto Nazionale dei Tumori
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2978609674